vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and ASCENT INDUSTRIES CO. (ACNT). Click either name above to swap in a different company.

ASCENT INDUSTRIES CO. is the larger business by last-quarter revenue ($11.9M vs $8.1M, roughly 1.5× Arcellx, Inc.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -766.0%, a 757.3% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs -79.3%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-63.9M). Over the past eight quarters, Arcellx, Inc.'s revenue compounded faster (-24.6% CAGR vs -34.9%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

ACLX vs ACNT — Head-to-Head

Bigger by revenue
ACNT
ACNT
1.5× larger
ACNT
$11.9M
$8.1M
ACLX
Growing faster (revenue YoY)
ACNT
ACNT
+92.6% gap
ACNT
13.3%
-79.3%
ACLX
Higher net margin
ACNT
ACNT
757.3% more per $
ACNT
-8.8%
-766.0%
ACLX
More free cash flow
ACNT
ACNT
$63.7M more FCF
ACNT
$-196.0K
$-63.9M
ACLX
Faster 2-yr revenue CAGR
ACLX
ACLX
Annualised
ACLX
-24.6%
-34.9%
ACNT

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
ACNT
ACNT
Revenue
$8.1M
$11.9M
Net Profit
$-62.3M
$-1.0M
Gross Margin
14.6%
Operating Margin
-847.6%
-21.0%
Net Margin
-766.0%
-8.8%
Revenue YoY
-79.3%
13.3%
Net Profit YoY
-765.1%
-1.2%
EPS (diluted)
$-1.13
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
ACNT
ACNT
Q4 25
$11.9M
Q3 25
$19.7M
Q2 25
$18.7M
Q1 25
$8.1M
$24.7M
Q4 24
$15.3M
$10.5M
Q3 24
$26.0M
$20.9M
Q2 24
$27.4M
$21.5M
Q1 24
$39.3M
$28.0M
Net Profit
ACLX
ACLX
ACNT
ACNT
Q4 25
$-1.0M
Q3 25
$-2.1M
Q2 25
$6.3M
Q1 25
$-62.3M
$-2.3M
Q4 24
$-47.1M
$-1.0M
Q3 24
$-25.9M
$-6.2M
Q2 24
$-27.2M
$-926.0K
Q1 24
$-7.2M
$-5.5M
Gross Margin
ACLX
ACLX
ACNT
ACNT
Q4 25
14.6%
Q3 25
29.7%
Q2 25
26.1%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACLX
ACLX
ACNT
ACNT
Q4 25
-21.0%
Q3 25
-4.1%
Q2 25
-14.4%
Q1 25
-847.6%
-4.2%
Q4 24
-348.2%
-25.4%
Q3 24
-129.1%
-9.4%
Q2 24
-127.8%
-8.6%
Q1 24
-40.3%
-15.5%
Net Margin
ACLX
ACLX
ACNT
ACNT
Q4 25
-8.8%
Q3 25
-10.6%
Q2 25
33.7%
Q1 25
-766.0%
-9.3%
Q4 24
-308.4%
-9.8%
Q3 24
-99.4%
-29.5%
Q2 24
-99.3%
-4.3%
Q1 24
-18.3%
-19.7%
EPS (diluted)
ACLX
ACLX
ACNT
ACNT
Q4 25
$-0.11
Q3 25
$-0.22
Q2 25
$0.65
Q1 25
$-1.13
$-0.23
Q4 24
$-0.87
$-0.11
Q3 24
$-0.48
$-0.61
Q2 24
$-0.51
$-0.09
Q1 24
$-0.14
$-0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
ACNT
ACNT
Cash + ST InvestmentsLiquidity on hand
$543.3M
$57.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$87.0M
Total Assets
$648.1M
$111.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
ACNT
ACNT
Q4 25
$57.6M
Q3 25
$58.0M
Q2 25
$60.5M
Q1 25
$543.3M
$14.3M
Q4 24
$587.4M
$16.1M
Q3 24
$574.3M
$8.5M
Q2 24
$516.7M
$3.6M
Q1 24
$573.9M
$1.3M
Total Debt
ACLX
ACLX
ACNT
ACNT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACLX
ACLX
ACNT
ACNT
Q4 25
$87.0M
Q3 25
$87.1M
Q2 25
$89.7M
Q1 25
$416.9M
$91.2M
Q4 24
$454.8M
$93.5M
Q3 24
$483.0M
$94.7M
Q2 24
$487.2M
$101.0M
Q1 24
$496.6M
$102.0M
Total Assets
ACLX
ACLX
ACNT
ACNT
Q4 25
$111.9M
Q3 25
$119.9M
Q2 25
$122.6M
Q1 25
$648.1M
$152.5M
Q4 24
$711.3M
$147.3M
Q3 24
$764.9M
$148.6M
Q2 24
$734.3M
$158.2M
Q1 24
$779.7M
$161.0M
Debt / Equity
ACLX
ACLX
ACNT
ACNT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
ACNT
ACNT
Operating Cash FlowLast quarter
$-63.1M
$266.0K
Free Cash FlowOCF − Capex
$-63.9M
$-196.0K
FCF MarginFCF / Revenue
-786.4%
-1.7%
Capex IntensityCapex / Revenue
9.6%
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
ACNT
ACNT
Q4 25
$266.0K
Q3 25
$1.3M
Q2 25
$-1.4M
Q1 25
$-63.1M
$-700.0K
Q4 24
$-46.0M
$8.8M
Q3 24
$30.7M
$3.4M
Q2 24
$-36.2M
$2.2M
Q1 24
$-31.9M
$263.0K
Free Cash Flow
ACLX
ACLX
ACNT
ACNT
Q4 25
$-196.0K
Q3 25
$695.0K
Q2 25
$-1.5M
Q1 25
$-63.9M
$-1.0M
Q4 24
$-47.5M
$8.4M
Q3 24
$28.4M
$3.1M
Q2 24
$-39.5M
$1.9M
Q1 24
$-38.3M
$25.0K
FCF Margin
ACLX
ACLX
ACNT
ACNT
Q4 25
-1.7%
Q3 25
3.5%
Q2 25
-8.3%
Q1 25
-786.4%
-4.1%
Q4 24
-311.3%
80.6%
Q3 24
109.2%
15.1%
Q2 24
-144.1%
9.1%
Q1 24
-97.7%
0.1%
Capex Intensity
ACLX
ACLX
ACNT
ACNT
Q4 25
3.9%
Q3 25
3.1%
Q2 25
0.8%
Q1 25
9.6%
1.3%
Q4 24
9.8%
3.7%
Q3 24
8.8%
1.3%
Q2 24
11.7%
1.0%
Q1 24
16.4%
0.9%
Cash Conversion
ACLX
ACLX
ACNT
ACNT
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

Related Comparisons